BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 27813086)

  • 1. Ultrasonography as an objective tool for assessment of infantile hemangioma treatment with propranolol.
    Rotter A; Samorano LP; de Oliveira Labinas GH; Alvarenga JG; Rivitti-Machado MC; Bouer M; Santos PC; Silvestre DA; de Oliveira ZN
    Int J Dermatol; 2017 Feb; 56(2):190-194. PubMed ID: 27813086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol in the management of infantile hemangiomas: clinical response and predictors.
    Balma-Mena A; Chakkittakandiyil A; Weinstein M; Lansang P; Ho N; Cammisuli S; Pope E
    J Cutan Med Surg; 2012; 16(3):169-73. PubMed ID: 22713439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol versus prednisone in the treatment of infantile hemangiomas: a retrospective comparative study.
    Bertrand J; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Powell J
    Pediatr Dermatol; 2011; 28(6):649-654. PubMed ID: 21995756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas.
    Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A
    Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of infantile capillary hemangioma of the eyelid with systemic propranolol.
    Vassallo P; Forte R; Di Mezza A; Magli A
    Am J Ophthalmol; 2013 Jan; 155(1):165-170.e2. PubMed ID: 22967870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of problematic infantile hemangiomas with propranolol: a series of 40 cases and review of the literature.
    Oksiuta M; Matuszczak E; Dębek W; Dzienis-Koronkiewicz E; Hermanowicz A; Tylicka M
    Postepy Hig Med Dosw (Online); 2014 Sep; 68():1138-44. PubMed ID: 25228522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence of infantile hemangiomas treated with propranolol.
    Bagazgoitia L; Hernández-Martín Á; Torrelo A
    Pediatr Dermatol; 2011; 28(6):658-662. PubMed ID: 22082463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic infantile hemangiomas treated with oral propranolol--a case series.
    Mhanna A; Franklin WH; Mancini AJ
    Pediatr Dermatol; 2011; 28(1):39-45. PubMed ID: 21261702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta blocker treatment for infantile hemangiomas.
    Rouhana HF; Fruge JH; Massengale WT
    Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rare presentations of infantile hemangiomas: 4 cases].
    Babic V; Schoeffler A; Moawad S; Mainard L; Schmutz JL; Bursztejn AC
    Ann Dermatol Venereol; 2018 Dec; 145(12):749-755. PubMed ID: 30415930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Routine Electrocardiography Necessary Before Initiation of Propranolol for Treatment of Infantile Hemangiomas?
    Yarbrough KB; Tollefson MM; Krol AL; Leitenberger SL; Mann JA; MacArthur CJ
    Pediatr Dermatol; 2016 Nov; 33(6):615-620. PubMed ID: 27599450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with propranolol for infantile hemangiomas: single-center experience.
    Turhan AB; Bör Ö; Özdemir ZC
    J Cosmet Dermatol; 2016 Sep; 15(3):296-302. PubMed ID: 27061310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines.
    Kumar MG; Coughlin C; Bayliss SJ
    Pediatr Dermatol; 2015; 32(2):171-9. PubMed ID: 25556828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of infantile hemangioma after termination of propranolol treatment.
    Chang L; Ma G; Jin Y; Ye X; Qiu Y; Chen H; Yu W; Yang X; Hu X; Lin X
    Ann Plast Surg; 2014 Feb; 72(2):173-5. PubMed ID: 24406852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parental experiences with propranolol versus oral corticosteroids for complicated infantile hemangioma, a retrospective questionnaire study.
    Hermans DJ; Zweegers J; Evers AW; Van Der Vleuten CJ
    Eur J Dermatol; 2013; 23(6):857-63. PubMed ID: 24185746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infantile hemangioma: treatment with short course systemic corticosteroid therapy as an alternative for propranolol.
    Nieuwenhuis K; de Laat PC; Janmohamed SR; Madern GC; Oranje AP
    Pediatr Dermatol; 2013; 30(1):64-70. PubMed ID: 22958179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol Therapy for Problematic Infantile Hemangioma.
    Ng M; Knuth C; Weisbrod C; Murthy A
    Ann Plast Surg; 2016 Mar; 76(3):306-10. PubMed ID: 26010350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralesional Bleomycin Injection for Propranolol-Resistant Hemangiomas.
    Chang L; Chen H; Yang X; Jin Y; Ma G; Lin X
    J Craniofac Surg; 2018 Mar; 29(2):e128-e130. PubMed ID: 29381619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol treatment of infantile hemangiomas: anticipatory guidance for parents and caretakers.
    Martin K; Blei F; Chamlin SL; Chiu YE; Frieden IJ; Frommelt PC; Garzon MC; Kwon EK; MacLellan-Tobert S; Mancini AJ; Seefeldt M; Sidbury R; Siegel DH; Drolet BA; Boucek RJ
    Pediatr Dermatol; 2013; 30(1):155-9. PubMed ID: 23316721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with Holter monitoring during propranolol therapy for infantile hemangiomas.
    Jacks SK; Kertesz NJ; Witman PM; Fernandez Faith E
    J Am Acad Dermatol; 2015 Aug; 73(2):255-7. PubMed ID: 26054433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.